Listed

Integra Lifesciences Holdings Corp

IARTNasdaqCIK 917520HealthcareFiscal year ends Dec 31

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Revenue$411.2m, Q3 FY2026
Operating income$18.9m, Q3 FY2026
Net income$14.9m, Q3 FY2026
Integra Lifesciences Holdings Corp, income statement, quarterly
Line itemUnitQ4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30Q3 FY20262026-09-30
Revenue$m397Revenue, Q4 FY2023, three months to 2023-12-31$397.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-26, accession 0000917520-26-000011. Derived: 12-month figure less the 9-month figure.Report this figure369Revenue, Q1 FY2024, three months to 2024-03-31$368.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-05-05, accession 0000917520-25-000041.Report this figure418Revenue, Q2 FY2024, three months to 2024-06-30$418.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-07-31, accession 0000917520-25-000074.Report this figure381Revenue, Q3 FY2024, three months to 2024-09-30$380.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-10-30, accession 0000917520-25-000096.Report this figure443Revenue, Q4 FY2024, three months to 2024-12-31$442.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-26, accession 0000917520-26-000011. Derived: 12-month figure less the 9-month figure.Report this figure383Revenue, Q1 FY2025, three months to 2025-03-31$382.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-05, accession 0000917520-26-000041.Report this figure416Revenue, Q2 FY2025, three months to 2025-06-30$415.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-07-29, accession 0000917520-26-000058.Report this figure402Revenue, Q3 FY2025, three months to 2025-09-30$402.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-10-23, accession 0000917520-26-000077.Report this figure435Revenue, Q4 FY2025, three months to 2025-12-31$434.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-26, accession 0000917520-26-000011. Derived: 12-month figure less the 9-month figure.Report this figure392Revenue, Q1 FY2026, three months to 2026-03-31$391.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-05, accession 0000917520-26-000041.Report this figure419Revenue, Q2 FY2026, three months to 2026-06-30$418.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-07-29, accession 0000917520-26-000058.Report this figure411Revenue, Q3 FY2026, three months to 2026-09-30$411.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-10-23, accession 0000917520-26-000077.Report this figure
Cost of revenue$m171Cost of revenue, Q4 FY2023, three months to 2023-12-31$170.5m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-K filed 2026-02-26, accession 0000917520-26-000011. Derived: 12-month figure less the 9-month figure.Report this figure162Cost of revenue, Q1 FY2024, three months to 2024-03-31$162.0m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2025-05-05, accession 0000917520-25-000041.Report this figure192Cost of revenue, Q2 FY2024, three months to 2024-06-30$192.3m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2025-07-31, accession 0000917520-25-000074.Report this figure181Cost of revenue, Q3 FY2024, three months to 2024-09-30$180.6m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2025-10-30, accession 0000917520-25-000096.Report this figure194Cost of revenue, Q4 FY2024, three months to 2024-12-31$193.6m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-K filed 2026-02-26, accession 0000917520-26-000011. Derived: 12-month figure less the 9-month figure.Report this figure188Cost of revenue, Q1 FY2025, three months to 2025-03-31$188.2m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-05-05, accession 0000917520-26-000041.Report this figure206Cost of revenue, Q2 FY2025, three months to 2025-06-30$206.3m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-07-29, accession 0000917520-26-000058.Report this figure195Cost of revenue, Q3 FY2025, three months to 2025-09-30$195.1m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-10-23, accession 0000917520-26-000077.Report this figure214Cost of revenue, Q4 FY2025, three months to 2025-12-31$214.1m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-K filed 2026-02-26, accession 0000917520-26-000011. Derived: 12-month figure less the 9-month figure.Report this figure175Cost of revenue, Q1 FY2026, three months to 2026-03-31$174.9m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-05-05, accession 0000917520-26-000041.Report this figure199Cost of revenue, Q2 FY2026, three months to 2026-06-30$199.0m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-07-29, accession 0000917520-26-000058.Report this figure201Cost of revenue, Q3 FY2026, three months to 2026-09-30$201.3m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-10-23, accession 0000917520-26-000077.Report this figure
Gross profit$mnot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Research and development$mnot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Selling, general and administrative$m163Selling, general and administrative, Q4 FY2023, three months to 2023-12-31$163.1m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2026-02-26, accession 0000917520-26-000011. Derived: 12-month figure less the 9-month figure.Report this figure166Selling, general and administrative, Q1 FY2024, three months to 2024-03-31$165.8m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-05-05, accession 0000917520-25-000041.Report this figure195Selling, general and administrative, Q2 FY2024, three months to 2024-06-30$195.5m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-07-31, accession 0000917520-25-000074.Report this figure177Selling, general and administrative, Q3 FY2024, three months to 2024-09-30$177.2m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-10-30, accession 0000917520-25-000096.Report this figure179Selling, general and administrative, Q4 FY2024, three months to 2024-12-31$178.5m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2026-02-26, accession 0000917520-26-000011. Derived: 12-month figure less the 9-month figure.Report this figure181Selling, general and administrative, Q1 FY2025, three months to 2025-03-31$181.5m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-05-05, accession 0000917520-26-000041.Report this figure180Selling, general and administrative, Q2 FY2025, three months to 2025-06-30$179.9m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-07-29, accession 0000917520-26-000058.Report this figure169Selling, general and administrative, Q3 FY2025, three months to 2025-09-30$169.0m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-10-23, accession 0000917520-26-000077.Report this figure169Selling, general and administrative, Q4 FY2025, three months to 2025-12-31$169.3m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2026-02-26, accession 0000917520-26-000011. Derived: 12-month figure less the 9-month figure.Report this figure178Selling, general and administrative, Q1 FY2026, three months to 2026-03-31$178.2m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-05-05, accession 0000917520-26-000041.Report this figure172Selling, general and administrative, Q2 FY2026, three months to 2026-06-30$172.4m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-07-29, accession 0000917520-26-000058.Report this figure165Selling, general and administrative, Q3 FY2026, three months to 2026-09-30$165.3m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-10-23, accession 0000917520-26-000077.Report this figure
Operating income$m36.0Operating income, Q4 FY2023, three months to 2023-12-31$36.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-26, accession 0000917520-26-000011. Derived: 12-month figure less the 9-month figure.Report this figure4.0Operating income, Q1 FY2024, three months to 2024-03-31$4.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-05-05, accession 0000917520-25-000041.Report this figure(3.0)Operating income, Q2 FY2024, three months to 2024-06-30−$3.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-07-31, accession 0000917520-25-000074.Report this figure(8.2)Operating income, Q3 FY2024, three months to 2024-09-30−$8.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-10-30, accession 0000917520-25-000096.Report this figure35.6Operating income, Q4 FY2024, three months to 2024-12-31$35.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-26, accession 0000917520-26-000011. Derived: 12-month figure less the 9-month figure.Report this figure(15.5)Operating income, Q1 FY2025, three months to 2025-03-31−$15.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-05, accession 0000917520-26-000041.Report this figure(513)Operating income, Q2 FY2025, three months to 2025-06-30−$512.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-07-29, accession 0000917520-26-000058.Report this figure11.8Operating income, Q3 FY2025, three months to 2025-09-30$11.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-10-23, accession 0000917520-26-000077.Report this figure23.0Operating income, Q4 FY2025, three months to 2025-12-31$23.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-26, accession 0000917520-26-000011. Derived: 12-month figure less the 9-month figure.Report this figure11.5Operating income, Q1 FY2026, three months to 2026-03-31$11.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-05, accession 0000917520-26-000041.Report this figure19.3Operating income, Q2 FY2026, three months to 2026-06-30$19.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-07-29, accession 0000917520-26-000058.Report this figure18.9Operating income, Q3 FY2026, three months to 2026-09-30$18.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-10-23, accession 0000917520-26-000077.Report this figure
Interest expense$m13.8Interest expense, Q4 FY2023, three months to 2023-12-31$13.8m. XBRL concept us-gaap:InterestExpense. 10-K filed 2024-02-28, accession 0000917520-24-000022. Derived: 12-month figure less the 9-month figure.Report this figure13.6Interest expense, Q1 FY2024, three months to 2024-03-31$13.6m. XBRL concept us-gaap:InterestExpense. 10-Q filed 2024-05-06, accession 0000917520-24-000061.Report this figure18.7Interest expense, Q2 FY2024, three months to 2024-06-30$18.7m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2025-07-31, accession 0000917520-25-000074.Report this figure19.4Interest expense, Q3 FY2024, three months to 2024-09-30$19.4m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2025-10-30, accession 0000917520-25-000096.Report this figure19.0Interest expense, Q4 FY2024, three months to 2024-12-31$19.0m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-K filed 2026-02-26, accession 0000917520-26-000011. Derived: 12-month figure less the 9-month figure.Report this figure18.8Interest expense, Q1 FY2025, three months to 2025-03-31$18.8m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-05-05, accession 0000917520-26-000041.Report this figure21.0Interest expense, Q2 FY2025, three months to 2025-06-30$21.0m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-07-29, accession 0000917520-26-000058.Report this figure22.7Interest expense, Q3 FY2025, three months to 2025-09-30$22.7m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-10-23, accession 0000917520-26-000077.Report this figure23.7Interest expense, Q4 FY2025, three months to 2025-12-31$23.7m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-K filed 2026-02-26, accession 0000917520-26-000011. Derived: 12-month figure less the 9-month figure.Report this figure22.5Interest expense, Q1 FY2026, three months to 2026-03-31$22.5m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-05-05, accession 0000917520-26-000041.Report this figure23.0Interest expense, Q2 FY2026, three months to 2026-06-30$23.0m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-07-29, accession 0000917520-26-000058.Report this figure23.0Interest expense, Q3 FY2026, three months to 2026-09-30$23.0m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-10-23, accession 0000917520-26-000077.Report this figure
Income tax$m9.0Income tax, Q4 FY2023, three months to 2023-12-31$9.0m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-02-26, accession 0000917520-26-000011. Derived: 12-month figure less the 9-month figure.Report this figure(1.9)Income tax, Q1 FY2024, three months to 2024-03-31−$1.9m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-05-05, accession 0000917520-25-000041.Report this figure(2.8)Income tax, Q2 FY2024, three months to 2024-06-30−$2.8m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-07-31, accession 0000917520-25-000074.Report this figure(9.7)Income tax, Q3 FY2024, three months to 2024-09-30−$9.7m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-10-30, accession 0000917520-25-000096.Report this figure3.1Income tax, Q4 FY2024, three months to 2024-12-31$3.1m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-02-26, accession 0000917520-26-000011. Derived: 12-month figure less the 9-month figure.Report this figure(4.7)Income tax, Q1 FY2025, three months to 2025-03-31−$4.7m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-05, accession 0000917520-26-000041.Report this figure(46.9)Income tax, Q2 FY2025, three months to 2025-06-30−$46.9m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-07-29, accession 0000917520-26-000058.Report this figure(1.4)Income tax, Q3 FY2025, three months to 2025-09-30−$1.4m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-10-23, accession 0000917520-26-000077.Report this figure6.0Income tax, Q4 FY2025, three months to 2025-12-31$6.0m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-02-26, accession 0000917520-26-000011. Derived: 12-month figure less the 9-month figure.Report this figure2.2Income tax, Q1 FY2026, three months to 2026-03-31$2.2m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-05, accession 0000917520-26-000041.Report this figure0.3Income tax, Q2 FY2026, three months to 2026-06-30$262.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-07-29, accession 0000917520-26-000058.Report this figure0.8Income tax, Q3 FY2026, three months to 2026-09-30$812.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-10-23, accession 0000917520-26-000077.Report this figure
Net income$m19.8Net income, Q4 FY2023, three months to 2023-12-31$19.8m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-26, accession 0000917520-26-000011. Derived: 12-month figure less the 9-month figure.Report this figure(3.3)Net income, Q1 FY2024, three months to 2024-03-31−$3.3m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-10-30, accession 0000917520-25-000096.Report this figure(12.4)Net income, Q2 FY2024, three months to 2024-06-30−$12.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-10-30, accession 0000917520-25-000096.Report this figure(10.7)Net income, Q3 FY2024, three months to 2024-09-30−$10.7m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-10-30, accession 0000917520-25-000096.Report this figure19.4Net income, Q4 FY2024, three months to 2024-12-31$19.4m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-26, accession 0000917520-26-000011. Derived: 12-month figure less the 9-month figure.Report this figure(25.3)Net income, Q1 FY2025, three months to 2025-03-31−$25.3m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-10-23, accession 0000917520-26-000077.Report this figure(484)Net income, Q2 FY2025, three months to 2025-06-30−$484.1m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-10-23, accession 0000917520-26-000077.Report this figure(5.4)Net income, Q3 FY2025, three months to 2025-09-30−$5.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-10-23, accession 0000917520-26-000077.Report this figure(1.7)Net income, Q4 FY2025, three months to 2025-12-31−$1.7m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-26, accession 0000917520-26-000011. Derived: 12-month figure less the 9-month figure.Report this figure(4.6)Net income, Q1 FY2026, three months to 2026-03-31−$4.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-10-23, accession 0000917520-26-000077.Report this figure4.5Net income, Q2 FY2026, three months to 2026-06-30$4.5m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-10-23, accession 0000917520-26-000077.Report this figure14.9Net income, Q3 FY2026, three months to 2026-09-30$14.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-10-23, accession 0000917520-26-000077.Report this figure
Diluted EPS$ per sharenot reported(0.04)Diluted EPS, Q1 FY2024, three months to 2024-03-31−$0.04 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-05-05, accession 0000917520-25-000041.Report this figure(0.16)Diluted EPS, Q2 FY2024, three months to 2024-06-30−$0.16 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-07-31, accession 0000917520-25-000074.Report this figure(0.14)Diluted EPS, Q3 FY2024, three months to 2024-09-30−$0.14 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-10-30, accession 0000917520-25-000096.Report this figurenot reported(0.33)Diluted EPS, Q1 FY2025, three months to 2025-03-31−$0.33 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-05, accession 0000917520-26-000041.Report this figure(6.31)Diluted EPS, Q2 FY2025, three months to 2025-06-30−$6.31 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-07-29, accession 0000917520-26-000058.Report this figure(0.07)Diluted EPS, Q3 FY2025, three months to 2025-09-30−$0.07 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-10-23, accession 0000917520-26-000077.Report this figurenot reported(0.06)Diluted EPS, Q1 FY2026, three months to 2026-03-31−$0.06 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-05, accession 0000917520-26-000041.Report this figure0.06Diluted EPS, Q2 FY2026, three months to 2026-06-30$0.06 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-07-29, accession 0000917520-26-000058.Report this figure0.19Diluted EPS, Q3 FY2026, three months to 2026-09-30$0.19 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-10-23, accession 0000917520-26-000077.Report this figure
Basic EPS$ per sharenot reported(0.04)Basic EPS, Q1 FY2024, three months to 2024-03-31−$0.04 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-05-05, accession 0000917520-25-000041.Report this figure(0.16)Basic EPS, Q2 FY2024, three months to 2024-06-30−$0.16 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-07-31, accession 0000917520-25-000074.Report this figure(0.14)Basic EPS, Q3 FY2024, three months to 2024-09-30−$0.14 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-10-30, accession 0000917520-25-000096.Report this figurenot reported(0.33)Basic EPS, Q1 FY2025, three months to 2025-03-31−$0.33 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-05, accession 0000917520-26-000041.Report this figure(6.31)Basic EPS, Q2 FY2025, three months to 2025-06-30−$6.31 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-07-29, accession 0000917520-26-000058.Report this figure(0.07)Basic EPS, Q3 FY2025, three months to 2025-09-30−$0.07 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-10-23, accession 0000917520-26-000077.Report this figurenot reported(0.06)Basic EPS, Q1 FY2026, three months to 2026-03-31−$0.06 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-05, accession 0000917520-26-000041.Report this figure0.06Basic EPS, Q2 FY2026, three months to 2026-06-30$0.06 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-07-29, accession 0000917520-26-000058.Report this figure0.19Basic EPS, Q3 FY2026, three months to 2026-09-30$0.19 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-10-23, accession 0000917520-26-000077.Report this figure

Balance sheet

Cash and equivalents$252.3m, Q3 FY2026
Long-term debt$697.5m, Q3 FY2026
Shareholders' equity$1.07bn, Q3 FY2026
Integra Lifesciences Holdings Corp, balance sheet, quarterly
Line itemUnitFY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30Q3 FY20262026-09-30
Cash and equivalents$m276Cash and equivalents, FY2023, at 2023-12-31$276.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2025-02-25, accession 0000917520-25-000017.Report this figure592Cash and equivalents, Q1 FY2024, at 2024-03-31$591.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-05-06, accession 0000917520-24-000061.Report this figure215Cash and equivalents, Q2 FY2024, at 2024-06-30$215.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-07-29, accession 0000917520-24-000094.Report this figure215Cash and equivalents, Q3 FY2024, at 2024-09-30$215.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-11-04, accession 0000917520-24-000108.Report this figure246Cash and equivalents, FY2024, at 2024-12-31$246.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-02-26, accession 0000917520-26-000011.Report this figure239Cash and equivalents, Q1 FY2025, at 2025-03-31$239.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-05-05, accession 0000917520-25-000041.Report this figure218Cash and equivalents, Q2 FY2025, at 2025-06-30$217.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-07-31, accession 0000917520-25-000074.Report this figure232Cash and equivalents, Q3 FY2025, at 2025-09-30$232.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-10-30, accession 0000917520-25-000096.Report this figure235Cash and equivalents, FY2025, at 2025-12-31$235.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-10-23, accession 0000917520-26-000077.Report this figure237Cash and equivalents, Q1 FY2026, at 2026-03-31$236.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-05, accession 0000917520-26-000041.Report this figure214Cash and equivalents, Q2 FY2026, at 2026-06-30$214.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-07-29, accession 0000917520-26-000058.Report this figure252Cash and equivalents, Q3 FY2026, at 2026-09-30$252.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-10-23, accession 0000917520-26-000077.Report this figure
Current assets$m1,058Current assets, FY2023, at 2023-12-31$1.06bn. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2025-02-25, accession 0000917520-25-000017.Report this figure1,416Current assets, Q1 FY2024, at 2024-03-31$1.42bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-05-06, accession 0000917520-24-000061.Report this figure1,112Current assets, Q2 FY2024, at 2024-06-30$1.11bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-07-29, accession 0000917520-24-000094.Report this figure1,100Current assets, Q3 FY2024, at 2024-09-30$1.10bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-11-04, accession 0000917520-24-000108.Report this figure1,082Current assets, FY2024, at 2024-12-31$1.08bn. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-02-26, accession 0000917520-26-000011.Report this figure1,107Current assets, Q1 FY2025, at 2025-03-31$1.11bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-05-05, accession 0000917520-25-000041.Report this figure1,143Current assets, Q2 FY2025, at 2025-06-30$1.14bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-07-31, accession 0000917520-25-000074.Report this figure1,144Current assets, Q3 FY2025, at 2025-09-30$1.14bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-10-30, accession 0000917520-25-000096.Report this figure1,160Current assets, FY2025, at 2025-12-31$1.16bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-10-23, accession 0000917520-26-000077.Report this figure1,172Current assets, Q1 FY2026, at 2026-03-31$1.17bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-05-05, accession 0000917520-26-000041.Report this figure1,191Current assets, Q2 FY2026, at 2026-06-30$1.19bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-07-29, accession 0000917520-26-000058.Report this figure1,190Current assets, Q3 FY2026, at 2026-09-30$1.19bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-10-23, accession 0000917520-26-000077.Report this figure
Total assets$m3,782Total assets, FY2023, at 2023-12-31$3.78bn. XBRL concept us-gaap:Assets. 10-K filed 2025-02-25, accession 0000917520-25-000017.Report this figure4,078Total assets, Q1 FY2024, at 2024-03-31$4.08bn. XBRL concept us-gaap:Assets. 10-Q filed 2024-05-06, accession 0000917520-24-000061.Report this figure4,074Total assets, Q2 FY2024, at 2024-06-30$4.07bn. XBRL concept us-gaap:Assets. 10-Q filed 2024-07-29, accession 0000917520-24-000094.Report this figure4,066Total assets, Q3 FY2024, at 2024-09-30$4.07bn. XBRL concept us-gaap:Assets. 10-Q filed 2024-11-04, accession 0000917520-24-000108.Report this figure4,037Total assets, FY2024, at 2024-12-31$4.04bn. XBRL concept us-gaap:Assets. 10-K filed 2026-02-26, accession 0000917520-26-000011.Report this figure4,053Total assets, Q1 FY2025, at 2025-03-31$4.05bn. XBRL concept us-gaap:Assets. 10-Q filed 2025-05-05, accession 0000917520-25-000041.Report this figure3,668Total assets, Q2 FY2025, at 2025-06-30$3.67bn. XBRL concept us-gaap:Assets. 10-Q filed 2025-07-31, accession 0000917520-25-000074.Report this figure3,646Total assets, Q3 FY2025, at 2025-09-30$3.65bn. XBRL concept us-gaap:Assets. 10-Q filed 2025-10-30, accession 0000917520-25-000096.Report this figure3,602Total assets, FY2025, at 2025-12-31$3.60bn. XBRL concept us-gaap:Assets. 10-Q filed 2026-10-23, accession 0000917520-26-000077.Report this figure3,578Total assets, Q1 FY2026, at 2026-03-31$3.58bn. XBRL concept us-gaap:Assets. 10-Q filed 2026-05-05, accession 0000917520-26-000041.Report this figure3,563Total assets, Q2 FY2026, at 2026-06-30$3.56bn. XBRL concept us-gaap:Assets. 10-Q filed 2026-07-29, accession 0000917520-26-000058.Report this figure3,508Total assets, Q3 FY2026, at 2026-09-30$3.51bn. XBRL concept us-gaap:Assets. 10-Q filed 2026-10-23, accession 0000917520-26-000077.Report this figure
Current liabilities$m307Current liabilities, FY2023, at 2023-12-31$307.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2025-02-25, accession 0000917520-25-000017.Report this figure302Current liabilities, Q1 FY2024, at 2024-03-31$302.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-05-06, accession 0000917520-24-000061.Report this figure328Current liabilities, Q2 FY2024, at 2024-06-30$328.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-07-29, accession 0000917520-24-000094.Report this figure913Current liabilities, Q3 FY2024, at 2024-09-30$912.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-11-04, accession 0000917520-24-000108.Report this figure922Current liabilities, FY2024, at 2024-12-31$922.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-02-26, accession 0000917520-26-000011.Report this figure918Current liabilities, Q1 FY2025, at 2025-03-31$918.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-05-05, accession 0000917520-25-000041.Report this figure930Current liabilities, Q2 FY2025, at 2025-06-30$929.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-07-31, accession 0000917520-25-000074.Report this figure364Current liabilities, Q3 FY2025, at 2025-09-30$364.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-10-30, accession 0000917520-25-000096.Report this figure456Current liabilities, FY2025, at 2025-12-31$456.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-10-23, accession 0000917520-26-000077.Report this figure347Current liabilities, Q1 FY2026, at 2026-03-31$346.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-05-05, accession 0000917520-26-000041.Report this figure331Current liabilities, Q2 FY2026, at 2026-06-30$330.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-07-29, accession 0000917520-26-000058.Report this figure329Current liabilities, Q3 FY2026, at 2026-09-30$329.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-10-23, accession 0000917520-26-000077.Report this figure
Total liabilities$m2,194Total liabilities, FY2023, at 2023-12-31$2.19bn. XBRL concept us-gaap:Liabilities. 10-K filed 2025-02-25, accession 0000917520-25-000017.Report this figure2,480Total liabilities, Q1 FY2024, at 2024-03-31$2.48bn. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-05-06, accession 0000917520-24-000061.Report this figure2,540Total liabilities, Q2 FY2024, at 2024-06-30$2.54bn. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-07-29, accession 0000917520-24-000094.Report this figure2,544Total liabilities, Q3 FY2024, at 2024-09-30$2.54bn. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-11-04, accession 0000917520-24-000108.Report this figure2,492Total liabilities, FY2024, at 2024-12-31$2.49bn. XBRL concept us-gaap:Liabilities. 10-K filed 2026-02-26, accession 0000917520-26-000011.Report this figure2,529Total liabilities, Q1 FY2025, at 2025-03-31$2.53bn. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-05-05, accession 0000917520-25-000041.Report this figure2,629Total liabilities, Q2 FY2025, at 2025-06-30$2.63bn. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-07-31, accession 0000917520-25-000074.Report this figure2,609Total liabilities, Q3 FY2025, at 2025-09-30$2.61bn. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-10-30, accession 0000917520-25-000096.Report this figure2,559Total liabilities, FY2025, at 2025-12-31$2.56bn. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-10-23, accession 0000917520-26-000077.Report this figure2,535Total liabilities, Q1 FY2026, at 2026-03-31$2.54bn. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-05-05, accession 0000917520-26-000041.Report this figure2,520Total liabilities, Q2 FY2026, at 2026-06-30$2.52bn. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-07-29, accession 0000917520-26-000058.Report this figure2,441Total liabilities, Q3 FY2026, at 2026-09-30$2.44bn. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-10-23, accession 0000917520-26-000077.Report this figure
Long-term debt$m775Long-term debt, FY2023, at 2023-12-31$775.0m. XBRL concept us-gaap:LongTermDebt. 10-K filed 2024-02-28, accession 0000917520-24-000022.Report this figure775Long-term debt, Q1 FY2024, at 2024-03-31$775.0m. XBRL concept us-gaap:LongTermDebt. 10-Q filed 2024-05-06, accession 0000917520-24-000061.Report this figure770Long-term debt, Q2 FY2024, at 2024-06-30$770.2m. XBRL concept us-gaap:LongTermDebt. 10-Q filed 2024-07-29, accession 0000917520-24-000094.Report this figure765Long-term debt, Q3 FY2024, at 2024-09-30$765.3m. XBRL concept us-gaap:LongTermDebt. 10-Q filed 2024-11-04, accession 0000917520-24-000108.Report this figure760Long-term debt, FY2024, at 2024-12-31$760.5m. XBRL concept us-gaap:LongTermDebt. 10-K filed 2025-02-25, accession 0000917520-25-000017.Report this figure756Long-term debt, Q1 FY2025, at 2025-03-31$755.6m. XBRL concept us-gaap:LongTermDebt. 10-Q filed 2025-05-05, accession 0000917520-25-000041.Report this figure746Long-term debt, Q2 FY2025, at 2025-06-30$745.9m. XBRL concept us-gaap:LongTermDebt. 10-Q filed 2025-07-31, accession 0000917520-25-000074.Report this figure736Long-term debt, Q3 FY2025, at 2025-09-30$736.3m. XBRL concept us-gaap:LongTermDebt. 10-Q filed 2025-10-30, accession 0000917520-25-000096.Report this figure727Long-term debt, FY2025, at 2025-12-31$726.6m. XBRL concept us-gaap:LongTermDebt. 10-K filed 2026-02-26, accession 0000917520-26-000011.Report this figure717Long-term debt, Q1 FY2026, at 2026-03-31$716.9m. XBRL concept us-gaap:LongTermDebt. 10-Q filed 2026-05-05, accession 0000917520-26-000041.Report this figure707Long-term debt, Q2 FY2026, at 2026-06-30$707.2m. XBRL concept us-gaap:LongTermDebt. 10-Q filed 2026-07-29, accession 0000917520-26-000058.Report this figure698Long-term debt, Q3 FY2026, at 2026-09-30$697.5m. XBRL concept us-gaap:LongTermDebt. 10-Q filed 2026-10-23, accession 0000917520-26-000077.Report this figure
Shareholders' equity$m1,588Shareholders' equity, FY2023, at 2023-12-31$1.59bn. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-02-26, accession 0000917520-26-000011.Report this figure1,598Shareholders' equity, Q1 FY2024, at 2024-03-31$1.60bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-10-30, accession 0000917520-25-000096.Report this figure1,534Shareholders' equity, Q2 FY2024, at 2024-06-30$1.53bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-10-30, accession 0000917520-25-000096.Report this figure1,522Shareholders' equity, Q3 FY2024, at 2024-09-30$1.52bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-10-30, accession 0000917520-25-000096.Report this figure1,545Shareholders' equity, FY2024, at 2024-12-31$1.55bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-10-23, accession 0000917520-26-000077.Report this figure1,524Shareholders' equity, Q1 FY2025, at 2025-03-31$1.52bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-10-23, accession 0000917520-26-000077.Report this figure1,039Shareholders' equity, Q2 FY2025, at 2025-06-30$1.04bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-10-23, accession 0000917520-26-000077.Report this figure1,038Shareholders' equity, Q3 FY2025, at 2025-09-30$1.04bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-10-23, accession 0000917520-26-000077.Report this figure1,043Shareholders' equity, FY2025, at 2025-12-31$1.04bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-10-23, accession 0000917520-26-000077.Report this figure1,042Shareholders' equity, Q1 FY2026, at 2026-03-31$1.04bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-10-23, accession 0000917520-26-000077.Report this figure1,043Shareholders' equity, Q2 FY2026, at 2026-06-30$1.04bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-10-23, accession 0000917520-26-000077.Report this figure1,067Shareholders' equity, Q3 FY2026, at 2026-09-30$1.07bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-10-23, accession 0000917520-26-000077.Report this figure

Cash flow

Operating cash flow$96.0m, Q3 FY2026
Capital expenditure$10.2m, Q3 FY2026
Share repurchases$0, Q3 FY2026
Integra Lifesciences Holdings Corp, cash flow, quarterly
Line itemUnitQ4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30Q3 FY20262026-09-30
Operating cash flow$m58.8Operating cash flow, Q4 FY2023, three months to 2023-12-31$58.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-26, accession 0000917520-26-000011. Derived: 12-month figure less the 9-month figure.Report this figure15.8Operating cash flow, Q1 FY2024, three months to 2024-03-31$15.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-05-05, accession 0000917520-25-000041.Report this figure40.4Operating cash flow, Q2 FY2024, three months to 2024-06-30$40.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-07-31, accession 0000917520-25-000074. Derived: 6-month figure less the 3-month figure.Report this figure22.5Operating cash flow, Q3 FY2024, three months to 2024-09-30$22.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-10-30, accession 0000917520-25-000096. Derived: 9-month figure less the 6-month figure.Report this figure50.7Operating cash flow, Q4 FY2024, three months to 2024-12-31$50.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-26, accession 0000917520-26-000011. Derived: 12-month figure less the 9-month figure.Report this figure(11.3)Operating cash flow, Q1 FY2025, three months to 2025-03-31−$11.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-05, accession 0000917520-26-000041.Report this figure8.9Operating cash flow, Q2 FY2025, three months to 2025-06-30$8.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-07-29, accession 0000917520-26-000058. Derived: 6-month figure less the 3-month figure.Report this figure40.9Operating cash flow, Q3 FY2025, three months to 2025-09-30$40.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-10-23, accession 0000917520-26-000077. Derived: 9-month figure less the 6-month figure.Report this figure11.8Operating cash flow, Q4 FY2025, three months to 2025-12-31$11.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-26, accession 0000917520-26-000011. Derived: 12-month figure less the 9-month figure.Report this figure9.8Operating cash flow, Q1 FY2026, three months to 2026-03-31$9.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-05, accession 0000917520-26-000041.Report this figure22.8Operating cash flow, Q2 FY2026, three months to 2026-06-30$22.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-07-29, accession 0000917520-26-000058. Derived: 6-month figure less the 3-month figure.Report this figure96.0Operating cash flow, Q3 FY2026, three months to 2026-09-30$96.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-10-23, accession 0000917520-26-000077. Derived: 9-month figure less the 6-month figure.Report this figure
Capital expenditure$m24.5Capital expenditure, Q4 FY2023, three months to 2023-12-31$24.5m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-26, accession 0000917520-26-000011. Derived: 12-month figure less the 9-month figure.Report this figure15.5Capital expenditure, Q1 FY2024, three months to 2024-03-31$15.5m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-05-05, accession 0000917520-25-000041.Report this figure29.7Capital expenditure, Q2 FY2024, three months to 2024-06-30$29.7m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-07-31, accession 0000917520-25-000074. Derived: 6-month figure less the 3-month figure.Report this figure29.6Capital expenditure, Q3 FY2024, three months to 2024-09-30$29.6m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-10-30, accession 0000917520-25-000096. Derived: 9-month figure less the 6-month figure.Report this figure29.6Capital expenditure, Q4 FY2024, three months to 2024-12-31$29.6m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-26, accession 0000917520-26-000011. Derived: 12-month figure less the 9-month figure.Report this figure28.9Capital expenditure, Q1 FY2025, three months to 2025-03-31$28.9m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-05, accession 0000917520-26-000041.Report this figure20.1Capital expenditure, Q2 FY2025, three months to 2025-06-30$20.1m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-07-29, accession 0000917520-26-000058. Derived: 6-month figure less the 3-month figure.Report this figure15.2Capital expenditure, Q3 FY2025, three months to 2025-09-30$15.2m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-10-23, accession 0000917520-26-000077. Derived: 9-month figure less the 6-month figure.Report this figure17.2Capital expenditure, Q4 FY2025, three months to 2025-12-31$17.2m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-26, accession 0000917520-26-000011. Derived: 12-month figure less the 9-month figure.Report this figure14.8Capital expenditure, Q1 FY2026, three months to 2026-03-31$14.8m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-05, accession 0000917520-26-000041.Report this figure12.3Capital expenditure, Q2 FY2026, three months to 2026-06-30$12.3m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-07-29, accession 0000917520-26-000058. Derived: 6-month figure less the 3-month figure.Report this figure10.2Capital expenditure, Q3 FY2026, three months to 2026-09-30$10.2m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-10-23, accession 0000917520-26-000077. Derived: 9-month figure less the 6-month figure.Report this figure
Share repurchases$m0.0Share repurchases, Q4 FY2023, three months to 2023-12-31$0. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-K filed 2026-02-26, accession 0000917520-26-000011. Derived: 12-month figure less the 9-month figure.Report this figure0.0Share repurchases, Q1 FY2024, three months to 2024-03-31$0. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2024-05-06, accession 0000917520-24-000061.Report this figure50.0Share repurchases, Q2 FY2024, three months to 2024-06-30$50.0m. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2025-07-31, accession 0000917520-25-000074. Derived: 6-month figure less the 3-month figure.Report this figure0.0Share repurchases, Q3 FY2024, three months to 2024-09-30$0. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2025-10-30, accession 0000917520-25-000096. Derived: 9-month figure less the 6-month figure.Report this figure2.5Share repurchases, Q4 FY2024, three months to 2024-12-31$2.5m. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-K filed 2026-02-26, accession 0000917520-26-000011. Derived: 12-month figure less the 9-month figure.Report this figurenot reportednot reported0.0Share repurchases, Q3 FY2025, three months to 2025-09-30$0. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2026-10-23, accession 0000917520-26-000077. Derived: 9-month figure less the 6-month figure.Report this figure0.0Share repurchases, Q4 FY2025, three months to 2025-12-31$0. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-K filed 2026-02-26, accession 0000917520-26-000011. Derived: 12-month figure less the 9-month figure.Report this figurenot reportednot reported0.0Share repurchases, Q3 FY2026, three months to 2026-09-30$0. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2026-10-23, accession 0000917520-26-000077. Derived: 9-month figure less the 6-month figure.Report this figure

Shares

Diluted shares (weighted)78.58m, Q3 FY2026
Integra Lifesciences Holdings Corp, shares, quarterly
Line itemUnitQ1 FY20232023-03-31Q2 FY20232023-06-30Q3 FY20232023-09-30Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q1 FY20262026-03-31Q2 FY20262026-06-30Q3 FY20262026-09-30
Diluted shares (weighted)m shares82.3Diluted shares (weighted), Q1 FY2023, three months to 2023-03-3182,323,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-05-06, accession 0000917520-24-000061.Report this figure81.2Diluted shares (weighted), Q2 FY2023, three months to 2023-06-3081,151,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-07-29, accession 0000917520-24-000094.Report this figure79.8Diluted shares (weighted), Q3 FY2023, three months to 2023-09-3079,811,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-11-04, accession 0000917520-24-000108.Report this figure77.7Diluted shares (weighted), Q1 FY2024, three months to 2024-03-3177,735,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-05-05, accession 0000917520-25-000041.Report this figure77.4Diluted shares (weighted), Q2 FY2024, three months to 2024-06-3077,409,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-07-31, accession 0000917520-25-000074.Report this figure76.4Diluted shares (weighted), Q3 FY2024, three months to 2024-09-3076,448,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-10-30, accession 0000917520-25-000096.Report this figure76.5Diluted shares (weighted), Q1 FY2025, three months to 2025-03-3176,463,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-05, accession 0000917520-26-000041.Report this figure76.7Diluted shares (weighted), Q2 FY2025, three months to 2025-06-3076,695,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-07-29, accession 0000917520-26-000058.Report this figure76.8Diluted shares (weighted), Q3 FY2025, three months to 2025-09-3076,753,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-10-23, accession 0000917520-26-000077.Report this figure77.0Diluted shares (weighted), Q1 FY2026, three months to 2026-03-3176,951,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-05, accession 0000917520-26-000041.Report this figure78.2Diluted shares (weighted), Q2 FY2026, three months to 2026-06-3078,168,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-07-29, accession 0000917520-26-000058.Report this figure78.6Diluted shares (weighted), Q3 FY2026, three months to 2026-09-3078,577,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-10-23, accession 0000917520-26-000077.Report this figure

Shares outstanding: 77.80mShares outstanding, period not labelled, at 2026-10-2277,800,976 shares. XBRL concept dei:EntityCommonStockSharesOutstanding. 10-Q filed 2026-10-23, accession 0000917520-26-000077.Report this figure at Oct 22, 2026, from the cover of the 10-Q filed Oct 23, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:28 ET. Listed shows no prices and gives no investment advice.